Acquired von Willebrand Syndrome Associated to Secondary IgM MGUS Emerging after Autologous Stem Cell Transplantation for AL Amyloidosis.

about

Acquired von Willebrand Disease Associated with Monoclonal Gammopathy of Unknown Significance.

P2860

Q47096816-6F1307D8-AF9B-42FA-A6D4-5838A2B020DF

P2860

Acquired von Willebrand Syndrome Associated to Secondary IgM MGUS Emerging after Autologous Stem Cell Transplantation for AL Amyloidosis.

Item

http://www.wikidata.org/entity/Q38781726

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Acquired von Willebrand Syndro ...... plantation for AL Amyloidosis.

@en

type

Item

label

Acquired von Willebrand Syndro ...... plantation for AL Amyloidosis.

@en

prefLabel

Acquired von Willebrand Syndro ...... plantation for AL Amyloidosis.

@en

P1476

Acquired von Willebrand Syndro ...... plantation for AL Amyloidosis.

@en

P2093

Adrienne Lee

http://www.w3.org/2001/XMLSchema#string

Hina Qamar

http://www.w3.org/2001/XMLSchema#string

Karen Valentine

http://www.w3.org/2001/XMLSchema#string

Leslie Skeith

http://www.w3.org/2001/XMLSchema#string

Victor H Jimenez-Zepeda

http://www.w3.org/2001/XMLSchema#string

P2860

Acquired von Willebrand syndrome: data from an international registry.

Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial.

Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.

Acquired von Willebrand syndrome: an update.

Light-chain amyloidosis: SCT, novel agents and beyond.

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement.

Autologous stem cell transplant for Al amyloidosis.

Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution.

Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.

Acquired von Willebrand syndrome associated with monoclonal gammopathy: a single-center study of 36 patients.

P304

e2017034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4084/MJHID.2017.034

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28512563

http://www.w3.org/2001/XMLSchema#string

P932

5419196

http://www.w3.org/2001/XMLSchema#string

Acquired von Willebrand Syndrome Associated to Secondary IgM MGUS Emerging after Autologous Stem Cell Transplantation for AL Amyloidosis.

about

P2860

P2860

Acquired von Willebrand Syndrome Associated to Secondary IgM MGUS Emerging after Autologous Stem Cell Transplantation for AL Amyloidosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932